advertising
-
1
Ghannoum MA, Hajjeh RA, Scher R, et al: A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol 43: 641, 2000.
-
2
Gupta AK, Stec N: Recent advances in therapies for onychomycosis and its management. F1000Res 8: F1000 Faculty Rev- 968, 2019.
-
3
Gupta AK, Jain HC, Lynde CW, et al: Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: a multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol 43: 244, 2000.
-
4
Gupchup GV, Zatz J: Structural characteristics and permeability properties of the human nail: a review. J Cosmet Sci 50: 363, 1999.
-
5
Roberts DT, Evans EG: Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol 138: 189, 1998.
-
6
Burkhart CN, Burkhart CG, Gupta AK: Dermatophytoma: recalcitrance to treatment because of existence of fungal biofilm. J Am Acad Dermatol 47: 629, 2002.
-
7
Carney C, Tosti A, Daniel R, et al: A new classification system for grading the severity of onychomycosis: onychomycosis severity index. Arch Dermatol 147: 1277, 2011.
-
8
Shimoyama H, Kuwano Y, Sei Y: Retrospective survey of treatment outcomes of efinaconazole 10% solution and luliconazole 5% solution for onychomycosis in our facility. Med Mycol J 60: 95, 2019.
-
9
Sigurgeirsson B: Prognostic factors for cure following treatment of onychomycosis. J Eur Acad Dermatol Venereol 24: 679, 2010.
-
10
Wang C, Cantrell W, Canavan T, et al: Successful treatment of dermatophytomas in 19 patients using efinaconazole 10% solution. Skin Appendage Disord 5: 304, 2019.
-
11
Peters MDJ, Marnie C, Tricco AC, et al: Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth 19: 3, 2021.
-
12
Gupta AK: Onychomycosis in the elderly. Drugs Aging 16: 397, 2000.
-
13
Gupta AK, Baran R: Ciclopirox nail lacquer solution 8% in the 21st century. J Am Acad Dermatol 43: S96, 2000.
-
14
Gupta AK: Ciclopirox nail lacquer: a brush with onychomycosis. Cutis 68: 13, 2001.
-
15
Gupta AK, Baran R, Summerbell R: Onychomycosis: strategies to improve efficacy and reduce recurrence. J Eur Acad Dermatol Venereol 16: 579, 2002.
-
16
Gupta AK, Buckley L: The limitations in the treatment of onychomycosis. J Am Acad Dermatol 60: AB117, 2009.
-
17
Shemer A, Daniel R, Rigopoulos D, et al: Variability in systemic treatment efficacy for onychomycosis: information that clinical studies do not impart to the office dermatologist. Skin Appendage Disord 4: 141, 2018.
-
18
Costa-Orlandi CB, Sardi JC, Santos CT, et al: In vitro characterization of Trichophyton rubrum and T. mentagrophytes biofilms. Biofouling 30: 719, 2014.
-
19
Gupta AK, Daigle D, Carviel JL: The role of biofilms in onychomycosis. J Am Acad Dermatol 74: 1241, 2016.
-
20
Verne SH, Chen L, Shah V, et al: Optical coherence tomography features of dermatophytoma. JAMA Dermatol 154: 225, 2018.
-
21
Martinez-Herrera E, Moreno-Coutiño G, Fernández-Martínez RF, et al: Dermatophytoma: description of 7 cases. J Am Acad Dermatol 66: 1014, 2012.
-
22
Leeyaphan C, Bunyaratavej S, Prasertworanun N, et al: Dermatophytoma: an under-recognized condition. Indian J Dermatol Venereol Leprol 82: 188, 2016.
-
23
Sato T, Horikawa H, Yamazaki K: Mold mite infestation in toenail dermatophytoma with pustular psoriasis. J Dtsch Dermatol Ges 18: 251, 2020.
-
24
Abdo HM: Excellent response of dermatophytoma and nail splitting to nail plate debridement plus topical ciclopirox olamine 1% solution. Skin Appendage Disord 7: 127, 2021.
-
25
Suzuki T, Sato T, Kasuya A, et al: A case of tinea faciei, tinea corporis, and tinea unguium with dermatophytoma successfully treated with oral fosravuconazole l-lysine ethanolate. Med Mycol J 62: 1, 2021.
-
26
Watanabe S, Iozumi K, Abe M, et al: Clinical effectiveness of efinaconazole 10% solution for treatment of onychomycosis with longitudinal spikes. J Dermatol 48: 1474, 2021.
-
27
Bennett D, Rubin AI: Dermatophytoma: a clinicopathologic entity important for dermatologists and dermatopathologists to identify. Int J Dermatol 52: 1285, 2013.
-
28
Lecha M, Effendy I, Feuilhade de Chauvin M, et al: Treatment options—development of consensus guidelines. J Eur Acad Dermatol Venereol 19 (suppl 1): 25, 2005.
-
29
Aly R, Winter T, Hall S, et al: Topical tavaborole in the treatment of onychomycosis complicated by dermatophytoma: a post-hoc assessment of phase II subjects. J Drugs Dermatol 17: 347, 2018.
-
30
Gupta AK, Paquet M: Management of onychomycosis in North America in 2014. J Am Acad Dermatol 70: AB91, 2014.
-
31
Park J, Nam JH, Lee JH, et al: Korean guideline for the diagnosis and treatment of onychomycosis: a consensus update by The Korean Society for Medical Mycology. Med Mycol 56: S95, 2018.
-
32
Lee MH, Suh MK, Ha GY: A clinico-mycological study of onychomycosis with dermatophytoma. Korean J Med Mycol 18: 21, 2013.
-
33
Sato T, Asahina Y, Toshima S, et al: Usefulness of Wood’s lamp for the diagnosis and treatment follow-up of onychomycosis. Med Mycol J 61: 17, 2020.
-
34
Cantrell W, Canavan T, Elewski B: Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution. J Drugs Dermatol 14: 524, 2015.
-
35
Shimoyama H, Yo A, Sei Y, et al: Treatment outcome with fosravuconazole for onychomycosis. Mycopathologia 186: 259, 2021.
-
36
Martínez E, Ameen M, Tejada D, et al: Microsporum spp. onychomycosis: disease presentation, risk factors and treatment responses in an urban population. Braz J Infect Dis 18: 181, 2014.
-
37
Sommer S, Sheehan-Dare RA, Goodfield MJ, et al: Prediction of outcome in the treatment of onychomycosis. Clin Exp Dermatol 28: 425, 2003.
-
38
Escalante K, Martínez E, Torres-Guerrero E, et al: Onychomycosis with dermatophytoma. A comparison among the results of treatments with oral terbinafine, topical 40% urea in monotherapy and combination therapy. Dermatol Klin 15: 67, 2013.
-
39
Goodfield MJD, Evans EGV: Combined treatment with surgery and short duration oral antifungal therapy in patients with limited dermatophyte toenail infection. J Dermatol Treatment 11: 259, 2000.
-
40
Chen B, Sun Y, Zhang J, et al: In vitro evaluation of photodynamic effects against biofilms of dermatophytes involved in onychomycosis. Front Microbiol 10: 1228, 2019.
-
41
Lipner SR, Joseph WS, Vlahovic TC, et al: Therapeutic recommendations for the treatment of toenail onychomycosis in the US. J Drugs Dermatol 20: 1076, 2021.
-
42
Gupta AK, Sibbald RG, Andriessen A, et al: Toenail onychomycosis—a Canadian approach with a new transungual treatment: development of a clinical pathway. J Cutan Med Surg 19: 440, 2015.
-
43
Ameen M, Lear JT, Madan V, et al: British Association of Dermatologists’ guidelines for the management of onychomycosis 2014. Br J Dermatol 171: 937, 2014.
-
44
Seebacher C, Brasch J, Abeck D, et al: Onychomycosis. Mycoses 50: 321, 2007.
-
45
Roberts DT, Taylor WD, Boyle J: Guidelines for treatment of onychomycosis. Br J Dermatol 148: 402, 2003.
-
46
Vlahovic TC, Joseph WS, Scher RK, et al: Diagnosis and management of onychomycosis perspectives from a joint podiatric medicine-dermatology roundtable. JAPMA 106: 155, 2016.
-
47
Vlahovic T: When a patient presents with linear streaks in a nail. Podiatry Today 28: 12, 2015.
-
48
Del Rosso JQ: The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. J Clin Aesthet Dermatol 7: 10, 2014.
-
49
Vlahovic TC, Gupta AK: Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients. Expert Rev Anti Infect Ther 20: 3, 2022.
-
50
Sakamoto M, Sugimoto N, Kawabata H, et al: Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails. J Drugs Dermatol 13: 1388, 2014.
-
51
Zeichner JA, Gold LS, Korotzer A: Penetration of (14C)-efinaconazole topical solution, 10%, does not appear to be influenced by nail polish. J Clin Aesthet Dermatol 7: 34, 2014.
-
52
Elewski BE, Pollak RA, Pillai R, et al: Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space. J Drugs Dermatol 13: 1394, 2014.
-
53
Costa-Orlandi CB, Martinez LR, Bila NM, et al: Nitric oxide-releasing nanoparticles are similar to efinaconazole in their capacity to eradicate trichophyton rubrum biofilms. Front Cell Infect Microbiol 11: 684150, 2021.
-
54
Castro LÁ, Álvarez MI: Nail dermatophytoma in HIV-infected patients in Cali, Colombia. J Mycol Med 31: 101172, 2021.
-
55
Bodman MA: Point-of-care diagnosis of onychomycosis by dermoscopy. JAPMA 107: 413, 2017.
-
56
Martínez-Herrera EO, Arroyo-Camarena S, Tejada-García DL, et al: Onychomycosis due to opportunistic molds. An Bras Dermatol 90: 334, 2015.
-
57
Prasertworonun N, Muanprasart C, Leeyaphan C, et al: Clinical manifestations of outpatients infected with Scytalidium dimidiatum: a retrospective study at Siriraj Hospital, Thailand. J Am Acad Dermatol 70: AB108, 2014.
Dermatophytomas in Onychomycosis: A Scoping Review of Prevalence, Diagnosis, and Treatment
Search for other papers by Shari R. Lipner in
Current site
Google Scholar
PubMed
Search for other papers by Tracey Vlahovic in
Current site
Google Scholar
PubMed
Search for other papers by Mahmoud A. Ghannoum in
Current site
Google Scholar
PubMed
Search for other papers by Boni Elewski in
Current site
Google Scholar
PubMed
Search for other papers by Warren S. Joseph in
Current site
Google Scholar
PubMed
Background: Dermatophytoma, also described as a longitudinal streak/spike, is a form of onychomycosis that presents as yellow/white streaks or patches in the subungual space, with dense fungal masses encased in biofilm. This scoping review of the literature was conducted to address a general lack of information about the epidemiology, pathophysiology, and treatment of dermatophytomas in onychomycosis.
Methods: A search was performed in the PubMed and Embase databases for the terms “longitudinal spike” or “dermatophytoma.” Outcomes of interest were definition, prevalence, methods used for diagnosis, treatments, and treatment efficacy. Inclusion and exclusion of search results required agreement between two independent reviewers.
Results: Of a total of 51 records, 37 were included. Two reports provided the first unique definitions/clinical features of dermatophytomas. Overall, many descriptions were found, but one conclusive definition was lacking. Prevalence data were limited and inconsistent. The most frequently mentioned diagnostic techniques were clinical assessment, potassium hydroxide/microscopy, and fungal culture/mycology. Oral terbinafine and topical efinaconazole 10% were the most frequently mentioned treatments, followed by topical luliconazole 5% and other oral treatments (itraconazole, fluconazole, fosravuconazole). In studies with five or more patients without nail excision, cure rates were highest with efinaconazole 10%, which ranged from 41% to 100% depending on the clinical and/or mycologic assessment evaluated. Other drugs with greater than or equal to 50% cure rates were topical luliconazole 5% (50%), oral fosravuconazole (57%), and oral terbinafine (67%). In studies that combined oral terbinafine treatment with nail excision using surgical or chemical (40% urea) methods, cure rates ranged from 50% to 100%.
Conclusions: There is little published information regarding dermatophytomas in onychomycosis. More clinical research and physician education are needed. Although dermatophytomas have historically been considered difficult to treat, the efficacy data gathered in this scoping review have demonstrated that newer topical treatments are effective, as are oral antifungals in combination with chemical or surgical methods.
advertising
